ABSCI CORPORATION Share Price Today: Live Updates & Key Insights

ABSCI CORPORATION share price today is $3.02, up -3.9%. The stock opened at $3.05 against the previous close of $3.08, with an intraday high of $3.2 and low of $2.9.

ABSCI CORPORATION Share Price Chart

ABSCI CORPORATION

us-stock
To Invest in {{usstockname}}
us-stock

ABSCI CORPORATION Share Price Performance

$3.02 -0.039(-3.9%) ABSI at 23 Mar 2026 11:51 AM Biotechnology
Lowest Today 2.9
Highest Today 3.2
Today’s Open 3.05
Prev. Close 3.08
52 Week High 5.23
52 Week Low 2.01
Day’s Range: Low 2.9 High 3.2
52-Week Range: Low 2.01 High 5.23
1 day return -
1 Week return +19.03
1 month return +12.07
3 month return -19.07
6 month return +10.82
1 year return -4.19
3 year return +75.73
5 year return -86.3
10 year return -

ABSCI CORPORATION Institutional Holdings

FMR Inc 14.88

ARK Investment Management LLC 8.35

ARK Genomic Revolution ETF 7.90

ARK Genomic Revolution 7.68

BlackRock Inc 7.04

Fidelity Growth Compy Commingled Pl S 6.60

Redmile Group, LLC 5.49

Vanguard Group Inc 5.26

Fidelity Growth Company Fund 4.59

Vanguard Total Stock Mkt Idx Inv 2.83

State Street® SPDR® S&P® Biotech ETF 2.27

iShares Russell 2000 ETF 2.24

Geode Capital Management, LLC 2.15

Ameriprise Financial Inc 2.12

Columbia Acorn Inst 1.71

Schonfeld Strategic Advisors LLC 1.56

Woodline Partners LP 1.52

Fidelity Growth Company K6 1.48

Baker Bros Advisors LP 1.42

State Street Corp 1.37

UBS Group AG 1.33

Citadel Advisors Llc 1.29

Fidelity Series Growth Company 1.27

Massachusetts Financial Services Company 1.14

Fidelity Select Biotechnology 1.02

Sumitomo Mitsui Trust Group Inc 0.99

Parkman Healthcare Partners LLC 0.97

Vanguard Institutional Extnd Mkt Idx Tr 0.97

Amova Asset Management Americas, Inc 0.95

Two Sigma Investments LLC 0.94

US Small-Cap Growth II Equity Comp 0.90

Fidelity Small Cap Index 0.89

MFS New Discovery I 0.84

Fred Alger Management, LLC 0.80

Charles Schwab Investment Management Inc 0.74

iShares Biotechnology ETF 0.68

ARK Venture D 0.63

iShares Russell 2000 Growth ETF 0.61

State St Russell Sm/Mid Cp® Indx SL Cl I 0.54

Fidelity Extended Market Index 0.47

ABSCI CORPORATION Market Status

Strong Buy: 5

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

ABSCI CORPORATION Fundamentals

Market Cap 445.10 M

PB Ratio 3.0616

PE Ratio 0.0

Enterprise Value 300.35 M

Total Assets 213.61 M

Volume 8377179

ABSCI CORPORATION Company Financials

Annual Revenue FY23:6937000 6.9M, FY22:5747000 5.7M, FY21:4782000 4.8M, FY20:4780000 4.8M, FY19:2060000 2.1M

Annual Profit FY23:null 0.0M, FY22:5747000 5.7M, FY21:4782000 4.8M, FY20:4780000 4.8M, FY19:2060000 2.1M

Annual Net worth FY23:-106492000 -106.5M, FY22:-104904000 -104.9M, FY21:-100960000 -101.0M, FY20:-14569000 -14.6M, FY19:-6801000 -6.8M

Quarterly Revenue Q3/2025:378000 0.4M, Q2/2025:593000 0.6M, Q1/2025:1179000 1.2M, Q3/2024:1701000 1.7M, Q2/2024:1270000 1.3M

Quarterly Profit Q3/2025:378000 0.4M, Q2/2025:-19865000 -19.9M, Q1/2025:-15185000 -15.2M, Q3/2024:1701000 1.7M, Q2/2024:-2114000 -2.1M

Quarterly Net worth Q3/2025:-28706000 -28.7M, Q2/2025:-30569000 -30.6M, Q1/2025:-26346000 -26.3M, Q3/2024:-27398000 -27.4M, Q2/2024:-24750000 -24.8M

About ABSCI CORPORATION & investment objective

Company Information Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.

Organisation Biotechnology

Employees 156

Industry Biotechnology

CEO Mr. Sean McClain

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

ABSCI CORPORATION FAQs

What is the share price of ABSCI CORPORATION today?

The current share price of ABSCI CORPORATION is $3.02.

Can I buy ABSCI CORPORATION shares in India?

Yes, Indian investors can buy ABSCI CORPORATION shares by opening an international trading and demat account with Motilal Oswal.

How to buy ABSCI CORPORATION shares in India?

You can easily invest in ABSCI CORPORATION shares from India by:

Can I buy fractional shares of ABSCI CORPORATION?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of ABSCI CORPORATION?

ABSCI CORPORATION has a market cap of $445.10 M.

In which sector does ABSCI CORPORATION belong?

ABSCI CORPORATION operates in the Biotechnology sector.

What documents are required to invest in ABSCI CORPORATION stocks?

To invest, you typically need:

What is the PE and PB ratio of ABSCI CORPORATION?

The PE ratio of ABSCI CORPORATION is N/A and the PB ratio is 3.06.